Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group

Atkins Michael B.; Hsu Jessie; Lee Sandra; Cohen Gary I.; Flaherty Lawrence E.; Sosman Jeffrey A.; Sondak Vernon K.; Kirkwood John M.

首页> 外文期刊>Journal of Clinical Oncology >Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group

【24h】

Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group

机译：III期试验比较与顺铂，长春碱，达卡巴嗪，白细胞介素-2和干扰素的生物疗法与单铂，芳嗪和脱酰毒毒素单独进行转移性恶性黑素瘤（E3695）的乳蛋白（E3695）：由东方合作肿瘤组协调的试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2008年第35期|共7页
作者
Atkins Michael B.; Hsu Jessie; Lee Sandra; Cohen Gary I.; Flaherty Lawrence E.; Sosman Jeffrey A.; Sondak Vernon K.; Kirkwood John M.;
展开▼
作者单位

Beth Israel Deaconess Med Ctr Boston MA 02215 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献

1. Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group [J] . Atkins Michael B., Hsu Jessie, Lee Sandra, Journal of Clinical Oncology . 2008,第35期

机译：转移性恶性黑色素瘤（E3695）患者单独进行顺铂，长春碱，达卡巴嗪，白细胞介素2和干扰素Alfa-2b与顺铂，长春碱和达卡巴嗪的同时生物化学疗法比较的第三阶段试验：由东部合作肿瘤小组协调进行的试验
2. Southwest oncology group S0008: A Phase III trial of high-dose interferon alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma-an intergroup study of cancer and leukemia group B, children's oncology group, eastern cooperative oncology group, and southwest oncology group [J] . FlahertyL.E., OthusM., AtkinsM.B., Journal of Clinical Oncology . 2014,第33期

机译：西南肿瘤学小组S0008：高剂量黑色素瘤患者中高剂量干扰素alfa-2b与顺铂，长春碱和达卡巴嗪联合白细胞介素2和干扰素的III期试验-癌症和白血病B组的儿童间研究肿瘤学组，东部合作肿瘤学组和西南肿瘤学组
3. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. [J] . Legha SS, Ring S, Eton O, Journal of Clinical Oncology . 1998,第5期

机译：转移性黑色素瘤患者同时化疗顺铂，长春碱，达卡巴嗪，干扰素α和白介素2的生物化学治疗方案的开发。
4. Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin Vinblastine Dacarbazine Interleukin-2 and Interferon Alfa-2b With Cisplatin Vinblastine and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group [O] . Michael B. Atkins, Jessie Hsu, Sandra Lee, -1

机译：转移性恶性黑色素瘤（E3695）患者单独进行顺铂长春碱达卡巴嗪白细胞介素2和干扰素Alfa-2b与顺铂长春碱和达卡巴嗪的并行生物化学治疗的第三阶段试验（E3695）：由东部合作肿瘤小组协调进行的试验
5. Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group [O] . Atkins, Michael B., Hsu, Jessie, Lee, Sandra, 2008

机译：转移性恶性黑色素瘤（E3695）患者单独进行顺铂，长春碱，达卡巴嗪，白细胞介素2和干扰素Alfa-2b与顺铂，长春碱和达卡巴嗪的并行生物化学治疗的第三阶段试验（E3695）：由东部合作肿瘤小组协调进行的试验

摘要

著录项

相似文献

相关主题

期刊订阅